Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancreatic Cancer

Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancreatic Cancer
复制标题

DOI:
10.1021/acs.molpharmaceut.7b00718
复制
发表时间:
2018-02-01
影响因子:
4.9
通讯作者:
Altomare, Deborah A.
Altomare, Deborah A.
中科院分区:
医学2区
文献类型:
--
作者:
Gitto, Sarah B.;Pandey, Veethika;Altomare, Deborah A.

文献摘要

被引文献

相似文献

胰腺导管腺癌(Pancreatic ductal adencarcinoma, PDAC)是一种高度耐药的肿瘤,预后极差,生存率为5年
Pancreatic ductal adenocarcinoma (PDAC) is highly chemo-resistant and has an extremely poor patient prognosis, with a survival rate at five years of